FilingSEC EDGARSCHEDULE 13D/ABridgeBio Oncology Therapeutics, Inc. filed Form SCHEDULE 13D/AJul 6, 2026, 16:37 ET · SEC acceptedSummaryFiling infoView sourceFiling contentPlease check the source for details.Related companiesBridgeBio Oncology Therapeutics, Inc.BBOTView stockLikeCommentsRepostShareComments —CommentLoading comments…
Comments —
Loading comments…